As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
The first of four planned modules at the new plant is expected to come online by summer 2026
Their findings, published in the journal Nature, reveal that the spines’ unique porous internal structure allows them to convert water movement into measurable electrical signals
Moderna will appeal to the Federal Circuit to assert that its government-contractor immunity limits liability under federal law
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
The facility is expected to become operational by FY2028-29
The new solution combines Watchmaker Genomics’ high-performance NGS chemistry with Volta’s digital fluidics platform
The VELO system supports multiplex testing for Influenza A, Influenza B, and COVID-19, producing PCR results in six to ten minutes
Operational leverage kicked in during the quarter, with adjusted EBITDA rising 21% year-on-year to Rs 147 crore
Subscribe To Our Newsletter & Stay Updated
